FDA Warning Letter — Bell International Laboratories, Inc.

Case 669736 — FEI 3005574978

The FDA took a Warning Letter action against Bell International Laboratories, Inc. on Feb 15, 2024 (Eagan, MN). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Bell International Laboratories, Inc.
Date
Feb 15, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Eagan, MN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.